跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 37 条关于
“CILFA”
全部
37
临床试验
20
药物
1
机构
0
资讯
16
6个月前
Argentina Repeals Restrictive Pharmaceutical Patent Guidelines, Sparking Industry Debate Over Generic Drug Access
2年前
CARVYKTI® Demonstrates Significant Benefit in High-Risk Multiple Myeloma After One Line of Therapy
去年
Cilta-cel Demonstrates Sustained Survival Benefit in Pretreated Multiple Myeloma
去年
Cilta-Cel Shows Promise in Earlier Multiple Myeloma Treatment Lines
去年
Cilta-cel Demonstrates Superiority Over Standard Care in Relapsed/Refractory Multiple Myeloma
2年前
Cilta-Cel Demonstrates High PFS Rates in High-Risk Multiple Myeloma
2年前
Cilta-cel Demonstrates Overall Survival Benefit in Relapsed/Refractory Multiple Myeloma
3年前
Cilta-cel Demonstrates Promising Results in Early and Late Relapsed Multiple Myeloma
3年前
Cilta-cel Shows Significant Reduction in Disease Progression in Relapsed/Refractory Multiple Myeloma
去年
Cilta-Cel Demonstrates Superiority Over Standard-of-Care Regimens in Lenalidomide-Refractory Multiple Myeloma
第 1 页,共 2 页
上一页
下一页